Merck and Bristol-Myers Squibb are key players in cancer treatment. Find out why MRK and BMY stocks have different prospects ...

ROCKFORD – Already facing long odds, the Black Hawk College women’s basketball team was thrown more adversity to deal with Saturday in its quest for a trip to the NJCAA Division II National ...

The drugmaker Merck announced it has opened a $1 billion vaccine manufacturing facility in north Durham, a ...

Given the economic conditions in China, Merck withdrew its previously issued long-term guidance of generating more than $11 billion in sales form Gardasil by 2030. Proquad, M-M-R II and Varivax ...

Merck, also known as MSD outside the U.S. and Canada, plans to significantly expand its workforce in India, aiming for around 2,700 employees by the year's end. The company focuses on therapy areas ...

Mer­ck said its “once-in-a-life­time” drug Keytru­da could be sub­ject to price re­duc­tions un­der the In­fla­tion Re­duc­tion Act, which would lead to a … ...

Merck is bracing for the years of sales growth from oncology superstar Keytruda to take a sharp turn in 2028—and for more reasons than one. Along with a key U.S. patent expiring at the end of ...